Align Technology, Inc. Profile Avatar - Palmy Investing

Align Technology, Inc.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It oper…
Medical - Devices
US, Tempe [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
74.76 78.38 75.31 74.35 75.45 75.95 75.71 75.50 75.81 73.63 72.46 71.33 74.26 70.52 70.39
Profit Margin
-10.01 19.18 13.91 10.48 9.74 19.15 17.03 17.57 15.71 20.35 18.40 71.84 19.53 9.68 11.52
Operating Margin
-10.89 26.54 18.84 15.28 14.27 25.42 22.31 23.05 24.00 23.73 16.93 11.88 24.70 17.21 17.02
EPS Growth
-137.50 317.78 -12.25 -15.12 9.59 126.25 -0.55 32.22 21.43 73.01 11.40 304.85 -56.63 -52.76 25.97
Return on Assets (ROA)
-8.80 15.57 10.28 7.76 7.73 14.76 12.43 13.59 13.02 19.50 17.71 36.77 12.99 6.08 7.32
Return on Equity (ROE)
-11.45 19.66 13.59 10.10 10.14 19.37 16.98 19.06 20.12 31.94 32.89 54.92 21.31 10.04 12.26
Return on Invested Capital (ROIC)
-11.49 17.23 11.90 10.10 10.14 19.51 17.07 19.55 19.47 32.32 23.21 41.45 19.86 10.40 12.14
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
- - 11.79 11.18 1.15 0.89 0.76 0.64 0.66 1.01 0.59 2.37 1.78 2.11 2.13 2.08
Debt/Equity
- - 14.89 14.79 1.50 1.17 0.99 0.88 0.93 1.56 0.96 4.40 2.67 3.46 3.52 3.49
Debt/EBITDA
530.65 -311.81 -259.34 -188.86 -99.14 -94.53 -81.16 -142.63 -127.12 -136.51 -104.21 -231.53 -102.08 -122.49 -103.46
Debt/Capitalization
- - 12.96 12.88 1.47 1.16 0.98 0.87 0.92 1.53 0.95 4.21 2.60 3.35 3.40 3.37
Interest Debt per Share USD
- - 0.74 0.93 0.11 0.09 0.09 0.09 0.12 0.22 0.15 0.75 0.99 2.05 1.69 1.63
Debt Growth
- - - - - - - - - - - - - - - - - - - - - - 48.28 59.29 23.63 -23.59
Liquidity
Current Ratio
321.63 417.98 259.81 305.46 310.64 325.63 269.45 268.95 232.42 188.20 168.23 139.52 129.62 125.88 118.39
Quick Ratio
296.64 396.57 229.28 272.81 275.61 289.58 252.45 250.52 209.79 169.69 146.13 122.10 107.51 96.54 90.78
Cash Ratio
204.92 316.93 162.49 192.65 138.56 99.04 61.73 109.86 90.30 92.03 56.69 72.48 57.14 48.92 45.36
Operating Cash Flow Ratio
- - 100 - - - - 100 100 - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
3,853.42 3,290.45 1,259.92 949.96 1,160.51 1,150.24 1,055.10 975.19 1,124.92 932.09 591.61 508.99 441.83 324.98 385.16
Receivables Turnover
572.70 591.66 524.10 565.74 582.96 587.01 533.26 436.46 456.41 447.94 437.37 375.84 440.55 434.42 427.51
Payables Turnover
1,287.83 1,077.61 614.89 734.84 791.43 632.13 426.20 925.23 969.29 807.12 759.77 498.63 620.69 860.92 1,010.87
Asset Turnover
87.92 81.17 73.89 74.05 79.34 77.09 72.97 77.35 82.88 95.81 96.24 51.18 66.52 62.79 63.48
Coverage
Interest Coverage
-40,014.12 540,705.26 177,176.47 - - - - - - - - - - - - - - - - -3,571.31 2,710.49 11,973.08 -30,802.58
Asset Coverage
- - - - - - - - - - - - - - - - - - - - 3,500 5,200 3,800 3,100 4,000
Cash Flow Coverage (CFGR)
- - 230.34 179.77 1,539.27 2,506.42 3,032.19 3,195.88 2,679.66 2,448.84 4,611.58 1,262.28 768.36 935.23 448.15 620.58
EBITDA Coverage
-36,900 497,300 181,900 - - - - - - - - - - - - - - - - -4,700 2,700 12,300 -38,000
Dividend Coverage
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
- - 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Yield
-2.54 5.01 3.61 2.63 1.40 3.23 2.73 2.47 1.30 2.39 2.00 4.22 1.49 2.19 2.13
Price/Earnings (P/E)
-3,937.62 1,995.37 2,773.35 3,807.49 7,158.70 3,096.00 3,657.73 4,047.07 7,689.15 4,189.49 5,005.35 2,369.96 6,717.79 4,560.70 4,705.22
Price/Book (P/B)
450.95 392.23 377.00 384.41 726.01 599.78 621.27 771.21 1,546.81 1,338.33 1,646.34 1,301.47 1,431.60 457.89 576.80
Price/Sales (P/S)
394.21 382.72 385.68 399.02 697.16 592.78 623.06 710.88 1,207.68 852.68 920.83 1,702.62 1,312.12 441.55 542.19
Price/Cash Flow (P/CF)
1,660.16 1,143.85 1,418.16 1,670.42 2,474.88 1,989.85 2,213.42 3,099.71 4,057.58 3,022.96 2,965.79 6,356.00 4,423.09 2,899.48 2,664.97
End of ALGN's Analysis
CIK: 1097149 CUSIP: 016255101 ISIN: US0162551016 LEI: - UEI: -
Secondary Listings